AUSTEDO

deutetrabenazine · Teva Neuroscience, Inc.

Drug timelines are a Plus or Pro feature.

15 regulatory and trial events tracked for AUSTEDO, covering 2017-04-03 to 2026-04-14. Get the full timeline:

Most recent: Clinical Trial Update: Impact of Deutetrabenazine on Functional Speech and Gait Dynamics in Huntington Disease [Phase 2, Phase 3]